<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03141021</url>
  </required_header>
  <id_info>
    <org_study_id>201702006</org_study_id>
    <nct_id>NCT03141021</nct_id>
  </id_info>
  <brief_title>Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors</brief_title>
  <official_title>Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      First, the investigators plan to use a retrospective analysis to determine the clinical
      landscape of neurofibromatosis (NF)1-associated malignant peripheral nerve sheath tumor
      (MPNST) and precursor lesions (e.g., atypical or nodular plexiform neurofibromas). A
      worldwide database will be established, collecting, in a standardized manner, histologic,
      immunohistochemical, molecular, radiographic, treatment, and related clinical data from
      centers worldwide with expertise in these NF1-related cancers. Although retrospective in
      nature, the resulting data from this registry may reveal previously unanticipated patterns,
      similar to the INFACT effort outcome. This registry would then allow the acquisition of data
      associated with MPNST biospecimens collected under associated banks (frozen or
      paraffin-embedded, germline (or normal tissue DNA) samples, and any previously somatic
      whole-exome or whole-genome sequencing data for aggregate analyses). Second, the
      investigators plan to co-register patients to institutional banks in order to prospectively
      collect MPNST samples for analysis. These patients will be consented in order to collect the
      above information and for banking of tumor tissue and future studies that include genomic
      characterization of the tumors.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 28, 2017</start_date>
  <completion_date type="Anticipated">April 28, 2027</completion_date>
  <primary_completion_date type="Anticipated">April 28, 2027</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Histologic characteristics of malignant peripheral nerve sheath tumor (MPNST)</measure>
    <time_frame>10 years</time_frame>
    <description>-The data collected through this registry will be used to analyze previously unanticipated patterns and prognostic clues about MPNST</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Immunohistochemical characteristics of malignant peripheral nerve sheath tumor (MPNST)</measure>
    <time_frame>10 years</time_frame>
    <description>-The data collected through this registry will be used to analyze previously unanticipated patterns and prognostic clues about MPNST</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Molecular characteristics of malignant peripheral nerve sheath tumor (MPNST)</measure>
    <time_frame>10 years</time_frame>
    <description>-The data collected through this registry will be used to analyze previously unanticipated patterns and prognostic clues about MPNST</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Radiographic characteristics of malignant peripheral nerve sheath tumor (MPNST)</measure>
    <time_frame>10 years</time_frame>
    <description>-The data collected through this registry will be used to analyze previously unanticipated patterns and prognostic clues about MPNST</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Treatment given to patients with malignant peripheral nerve sheath tumor (MPNST)</measure>
    <time_frame>10 years</time_frame>
    <description>-The data collected through this registry will be used to analyze previously unanticipated patterns and prognostic clues about MPNST</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Future genomic characterization of malignant peripheral nerve sheath tumor (MPNST)</measure>
    <time_frame>10 years</time_frame>
    <description>-The data collected through this registry will be used to analyze previously unanticipated patterns and prognostic clues about MPNST</description>
  </primary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Malignant Peripheral Nerve Sheath Tumors</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Biospecimens collected under associated banks (frozen or paraffin-embedded, germline (or
      normal tissue DNA) samples, and any previously somatic whole-exome or whole-genome sequencing
      data for aggregate analyses) and prospectively collect MPNST samples for analysis.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The oncology clinic of each participating institution
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria and Exclusion Criteria:

        -Any patient diagnosed with an MPNST is eligible for enrollment to this registry provided
        s/he consents to participate (or consent form his/her parent or legal guardian is
        obtained).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Angela Hirbe, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Washington University School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Angela Hirbe, M.D., Ph.D.</last_name>
    <phone>(314) 362-8965</phone>
    <email>hirbea@wustl.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Institutes of Health (NIH)</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jack F Shern, M.D.</last_name>
      <phone>301-402-1444</phone>
      <email>john.shern@nih.gov</email>
    </contact>
    <investigator>
      <last_name>Jack F Shern, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Washington University School of Medicine</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angela Hirbe, M.D., Ph.D.</last_name>
      <phone>314-362-8965</phone>
      <email>hirbea@wustl.edu</email>
    </contact>
    <investigator>
      <last_name>Angela Hirbe, M.D., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Gutmann, M.D., Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sonika Dahiya, M.D., MBBS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Brian Van Tine, M.D., Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Peter Oppelt, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Memorial Sloan Kettering Cancer Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ping Chi, M.D., Ph.D.</last_name>
      <phone>646-888-4166</phone>
    </contact>
    <investigator>
      <last_name>Ping Chi, M.D., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.siteman.wustl.edu</url>
    <description>Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine</description>
  </link>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 13, 2017</study_first_submitted>
  <study_first_submitted_qc>May 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 4, 2017</study_first_posted>
  <last_update_submitted>April 17, 2018</last_update_submitted>
  <last_update_submitted_qc>April 17, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nerve Sheath Neoplasms</mesh_term>
    <mesh_term>Neurofibroma</mesh_term>
    <mesh_term>Neurilemmoma</mesh_term>
    <mesh_term>Neurofibrosarcoma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

